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Tumor cells get primitive
 
hen metastatic tumor cells 
 
migrate through connective tissue, 
they use proteases to chew a path for 
themselves. This finding led to the 
development of protease inhibitors as 
potential cancer therapies, but some 
animal and human clinical tests of these 
drugs have been disappointing. Wolf et 
al., reporting on page 267, may have 
found one reason why: when proteolysis 
 
is inhibited, tumor cells resort to an 
amoeboid type of movement that allows 
them to squeeze through cracks in the 
matrix. The results provide substantial 
new insight into cell migration in multi-
cellular organisms.
Using both in vitro and in vivo cell 
 
migration systems, the authors investigated 
the effects of inhibiting proteases that 
degrade the extracellular matrix. Normally, 
transformed cells migrate through three-
dimensional collagen matrices or the 
mouse dermis as individual, spindle-
shaped cells, using several proteolytic 
enzymes and leaving trails through the 
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Venus dye trap catches executioners
 
luorescence resonance energy transfer (FRET) between 
 
coupled fluorescent proteins is a promising tool for studying 
caspase activation during apoptosis. Unfortunately, current 
 
FRET systems are acutely sensitive to changes in pH and 
 
chloride ion concentration, and since these fluctuate considerably 
during apoptosis the results of FRET experiments are often 
difficult to interpret. Takemoto et al., whose report appears on 
page 235, developed a new FRET system that is resistant to 
acidification and chloride, and used it to obtain a detailed 
view of caspase-3 and caspase-9 activation in apoptosis. The 
new technique should also enable studies of caspase activity 
in vivo that were previously impossible.
F
Caspase 3 is activated first in the cytoplasm (left) and then in the 
nucleus (right).
 
matrix. When the proteases are shut down, 
cells undergo a striking change in their 
appearance, reminiscent of a transition 
toward amoeboid movement. The cells 
then continue to migrate through the 
 
matrix without breaking it down and 
without leaving trails. 
The change in migration strategy, 
 
which Wolf et al. call the mesenchymal–
amoeboid transition, suggests that the 
cells of multicellular organisms retain a 
more primitive migration system that is 
normally masked. This type of migration, 
similar to the movement of the soil 
 
amoeba 
 
Dictyostelium discoideum
 
, could 
serve as a “salvage” pathway, allowing 
tumor cells to take a step backward in 
evolutionary time to continue migrating 
in the presence of protease inhibitors. 
Amoeboid movement may also have 
more positive functions in multicellular 
organisms; in separate work, T lympho-
cytes have been shown to migrate through 
collagen matrices without using proteases. 
The authors are now trying to identify 
the regulatory pathways responsible for 
controlling the mesenchymal–amoeboid 
transition. Targeting this process while 
simultaneously inhibiting proteases 
might provide a salvage pathway for 
 
new tumor therapies as well.
 
 
 
 
Protease-inhibited cells squeeze through 
the matrix using ameboid-like movements.
 
To make a caspase-sensitive FRET system, two fluorescent 
proteins, a donor and an acceptor, are linked with a cleavage 
site that can be cut by a particular caspase. Caspase activity is 
then detected as a change in fluorescence. The authors used 
a new variant of enhanced yellow fluorescent protein called 
Venus as the acceptor, and linked it to a donor protein through 
either a caspase-3 or caspase-9 cleavage sequence. Both 
systems are resistant to acidification and high chloride ion 
concentrations.
The new systems show that, when apoptosis is induced, 
caspase-3 is activated rapidly in the cytosol and nucleus, 
 
reaching full activation before apoptotic morphological changes 
begin. This suggests that activated caspase-3 may enter the 
nucleus to induce the early structural changes. Caspase-9 is 
initially activated at the same time as caspase-3, but does not 
become fully activated until the morphological changes are 
well underway.
The authors have now developed a line of transgenic flies 
expressing the caspase-3 indicator system, and hope to have a 
transgenic mouse system soon. The ability to monitor caspase 
activity in whole tissues should make it possible to study the 
early steps of this important process, before the apoptotic cells 
are engulfed by their neighbors. 
 
 